Highly Active Antiretroviral Therapy for Patients With Primary Biliary Cirrhosis (HAART)

This study has been completed.
Sponsor:
Collaborators:
Abbott
Gilead Sciences
Canadian Institutes of Health Research (CIHR)
Information provided by (Responsible Party):
Andrew L. Mason, University of Alberta
ClinicalTrials.gov Identifier:
NCT01614405
First received: April 25, 2011
Last updated: November 30, 2015
Last verified: December 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: August 2015
  Primary Completion Date: July 2015 (Final data collection date for primary outcome measure)